Möchten Sie immer auf dem neuesten Stand bleiben?

IRVINE, CA--(Marketwired - Aug 7, 2013) - Biomerica, Inc. (OTCBB: BMRA) announced today that it has received approval to market and sell its H. Pylori and Parathyroid Hormone (PTH) diagnostic tests...

IRVINE, CA--(Marketwired - Apr 16, 2013) - Biomerica, Inc. (OTCBB: BMRA) today reported net sales of $5,002,418 for the nine months ending February 28, 2013, compared to $4,538,944 for the same...

IRVINE, CA--(Marketwire - Jan 15, 2013) - Biomerica, Inc. (OTCBB: BMRA) today reported net sales of $1,883,771 for the three months ended November 30, 2012, compared to $1,616,606 for the same...

IRVINE, CA--(Marketwire - Oct 15, 2012) - Biomerica, Inc. (OTCBB: BMRA), a global provider of advanced diagnostic products for the early detection of medical conditions, announced financial results...

IRVINE, CA--(Marketwire - Aug 30, 2012) - Biomerica, Inc. (OTCBB: BMRA), a global provider of advanced diagnostic products for the early detection of medical conditions, today reported net income...

IRVINE, CA--(Marketwire - Apr 17, 2012) - Biomerica, Inc. (OTCBB: BMRA) today reported net income for the nine months ended February 29, 2012 of $494,329 compared to a net income of $61,354 during...

IRVINE, CA--(Marketwire - Mar 6, 2012) - Biomerica, Inc. (OTCBB: BMRA) announced today that it has introduced two new E. coli tests for detecting verotoxin and E. coli 0157. E. coli is an...

IRVINE, CA--(Marketwire - Jan 31, 2012) - Biomerica, Inc. (OTCBB: BMRA) announced that it has launched a new patented Thiopurine methyltransferase (TPMT) test to detect patients who are at risk of...

IRVINE, CA--(Marketwire - Jan 18, 2012) - Biomerica, Inc. (OTCBB: BMRA) today reported net sales of $1,616,606 for the three months ended November 30, 2011, compared to $1,160,842 for the same...

IRVINE, CA--(Marketwire - Oct 18, 2011) - Biomerica, Inc. (OTCBB: BMRA), a global provider of advanced diagnostic products for the early detection of medical conditions, announced financial results...